查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1835397

静脉输液袋市场按应用、材料、包装类型、流量、最终用户和产品类型划分－全球预测，2025-2032

IV Bags Market by Application, Material, Packaging Type, Flow Rate, End User, Product Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，静脉输液袋市场规模将成长至 472.7 亿美元，复合年增长率为 7.27%。

主要市场统计数据
基准年2024年 269.5亿美元
预计2025年 289.1亿美元
预测年份：2032年 472.7亿美元
复合年增长率（%） 7.27%

多方面 IV 环境的简明说明，重点关注临床使用案例、材料演变和决定供应商和提供者选择的结构部分

输液系统仍然是急性和慢性护理的基本组成部分，在各种临床环境中支援液体治疗、药物管理、营养支持和紧急復苏。近年来，各种压力不断增加，静脉输液袋设计和输送的战略重要性也日益凸显，包括转向不使用传统塑化剂的材料科学、更加重视患者安全和药物相容性，以及输送方式从医疗机构扩展到居家照护和门诊。这些因素共同迫使製造商和医疗保健提供者重新思考其产品组合、采购方法和临床工作流程。

相关人员在评估产品选择时必须考虑市场结构的多个面向。按应用划分，市场涵盖门诊护理、居家照护和医院，其中医院环境进一步细分为普通病房、ICU、手术室等。按材料划分，市场主要关注非 PVC 和 PVC 选项，其中 PVC 进一步分为乙烯醋酸乙烯酯和聚烯。按包装类型划分，设备分为多腔和单腔配置，其中多腔设备进一步分为双腔和三腔。依流速划分，临床应用分为大滴灌和微滴灌系统。按最终用户划分，市场包括门诊护理中心、诊所、居家照护中心和医院。按产品类型划分，市场分析包括特殊药物输送、标准静脉输液和全肠外营养。这个多维框架是以下章节所探讨的分析主题的基础。

确定将影响输液解决方案设计、製造优先顺序和临床部署策略的材料、监管和护理服务转型

静脉输液袋市场正在经历一场变革性的转变，这得益于材料创新、不断变化的监管环境以及医疗服务模式的转变，这些因素正在全面重塑产品规格和采购逻辑。由于对塑化剂迁移、药物相容性和环境永续性的担忧，聚合物科学的进步正在加速传统PVC配方替代品的采用。因此，製造商正在投资乙烯醋酸乙烯酯和聚烯的加工能力，以满足临床医生对更安全、化学惰性容器的需求。

同时，医疗保健服务正日益分散化。门诊和居家医疗机构正在拓展先前仅限于医院的医疗服务，因此更加重视能够简化非临床环境下给药并降低给药风险的包装形式。诸如大滴灌和微滴灌装置等流量匹配解决方案也正在获得差异化的临床应用。此外，数位可追溯性和一次性使用管理计画正在改变生命週期经济学。总而言之，这些趋势要求供应商必须根据不断变化的临床和商业性参数，调整其研发、製造能力和监管策略。

分析 2025 年关税造成的累积营运和商业影响以及它们如何影响供应商策略、库存设计和采购选择。

2025年实施的关税及相关贸易措施正在对整个静脉注射药品供应链的采购成本、供应商选择和库存策略产生累积影响。关税带来的成本压力正促使下游买家重新评估其采购区域，并专注于供应商多元化和近岸外包，以缓衝贸易政策波动带来的风险。采购团队在重新配置供应商层级时，越来越多地在到岸成本与供应商可靠性、监管部门的核准和品质认证之间取得平衡。

实际上，製造商和合约包装商正在调整定价模式，并与原材料供应商重新协商合同，以在保持无菌和合规标准的同时保护净利率。跨境运输的行政负担不断增加，这提升了垂直整合供应商和区域製造地的价值，这些供应商和基地能够满足当地需求，同时降低海关手续的复杂性。库存政策正在转向一种混合方法，将战略安全库存与大批量产品的即时补货相结合，并辅以增强的可视性工具。整体而言，关税环境正在加速有利于弹性、可追溯性和灵活生产能力的结构性调整。

详细的細項分析揭示了应用、材料选择、包装结构、流动特性、最终用户环境和产品类型如何推动差异化的临床和商业性需求

细分洞察揭示了涵盖临床环境、材料、包装形式、流程配置、最终用户类型和产品类型的细微变化轨迹，每个轨迹都具有独特的策略意义。医院本身对不同用例（例如普通病房、ICU 和手术室）也有不同的需求，这些差异会影响容器的坚固性、相容性规格和标籤检视清晰度。从 PVC 转向非 PVC 材料（例如乙烯醋酸乙烯和聚烯）的转变，是出于对药物交互作用和环境方面的考虑，这需要对製造流程和验证通讯协定进行相应的更改。

包装类型已成为产品差异化的关键点。虽然单腔解决方案仍然是标准输液的核心，但包括双腔和三腔设计在内的多腔形式在特殊药物传输和照护现场混合疗法中越来越受欢迎。大滴和微滴的流速反映了特定的临床应用，其中大滴针对快速液体復苏进行了优化，微滴针对儿科和门诊环境中的精准给药进行了优化。最终使用者包括门诊护理中心、诊所、居家照护中心和医院，需要量身定制的培训、标籤和分销方式。特殊药物输送、标准输液和全肠外营养等产品类型进一步影响了保质期要求、相容性测试以及对低温运输或受控环境包装的需求。这些细分洞察应指南产品系列的合理化、有针对性的产能投资以及临床市场准入。

美洲、欧洲、中东和非洲以及亚太地区的动态将如何影响製造选择、监管导航和临床采用模式的区域比较

区域动态正在塑造供给侧能力和需求模式，每个宏观区域都展现出不同的法规结构、製造生态系统和临床应用曲线。在美洲，成熟的临床基础设施和强大的采购管道促进了新材料和高利润特种产品的快速应用，而製造商与大型医疗保健系统的接近性则支持了在合规性和产品测试方面的密切合作。在欧洲、中东和非洲，监管多样性和报销差异为能够驾驭国家医疗保健系统和当地审批途径的供应商带来了挑战和机会，而区域中心对于分销和本地生产仍然至关重要。

在亚太地区，生产规模和成本竞争力仍然至关重要，这得益于越来越多的聚合物加工商和契约製造能够同时供应国内和出口市场。该地区的门诊和居家医疗机构的临床应用也在加速，这推动了对用户友好型和分散式包装的需求。包括关税和物流限制在内的区域贸易动态正在推动更本地化的生产力计画方法，许多公司采用区域製造布局，以缩短前置作业时间并减少监管摩擦。这些地理区域划分应体现在打入市场策略、监理投资和供应链设计。

企业策略洞察，展示製造商和供应商如何利用材料创新、品质系统和伙伴关係模式来获得临床和商业性优势

公司层级的行动体现了一系列通用的策略性应对措施，包括投资材料创新、提升无菌生产能力，以及寻求策略伙伴关係和製造外包协议以加速产能部署。领先的公司正在透过高效的非PVC製剂生产线实现差异化，以解决药物相容性和安全性问题；而其他公司则正在优化PVC製剂配方，以提升其生命週期成本和性能优势。同时，一些公司正在开发多腔解决方案和专用输送系统，以占领更高价值的临床市场，并满足临床医生对简化混合和缩短准备时间的需求。

在营运方面，企业优先考虑监管协调、品管体係以及跨製造和分销管道的数位可追溯性，以满足买家对透明度和信任度的期望。一些企业也正在探索永续性倡议，例如使用可回收材料、降低灭菌能耗以及尽量减少包装，作为其采购决策中的差异化因素。这些策略倡议表明，该行业正在平衡渐进式产品演进和有针对性的技术创新，以应对临床复杂性、监管审查和供应链弹性等多重压力。

为製造商、供应商和采购领导者提供优先、可行的建议，以提高其静脉输液产品系列的弹性、创新和市场应对力

产业领导者应采取一系列优先可行的措施，使营运能力与不断变化的临床需求和政策环境保持一致。首先，实现供应商多元化，并建立区域性生产缓衝机制，以维持对本地需求的应对力，同时降低跨境政策风险。其次，加快对乙烯醋酸乙烯酯和聚烯等非PVC材料的投资，同时在临床适用的领域保留可行的PVC选择，确保产品系列符合各种相容性和永续性标准。

第三，在临床上重视输液便利性和药物稳定性的领域，我们将优先考虑多腔和专用输送平台，并调整门诊和居家照护环境下的包装和标籤。第四，我们将投资数位可追溯性和库存优化工具，以提高供应视觉性，消除浪费，并实施平衡安全库存和高效週转的混合库存策略。第五，我们将积极与监管机构和大型采购商合作，简化核准流程，使产品规格与采购要求保持一致。最后，我们将与临床领导者建立有针对性的伙伴关係关係，以检验产品在重症监护室、手术室和家庭环境中的性能，从而缩短产品应用曲线并强化我们的价值提案。

对研究通讯协定进行透明的描述，结合对临床医生和供应商的初步调查、技术审查、供应链映射和三角二次分析，可以得出可靠的结论

该研究将结构化一手访谈、技术白皮书、监管文件和上市公司披露的证据与供应链图谱和以材料为中心的实验室评估相结合。一手研究包括与医院病房、ICU团队和门诊的临床医生、采购专业人员、委託製造和聚合物供应商的对话。二级资讯来源提供了法规发展、灭菌通讯协定和设备相容性文献的背景检验，以支援对产品和製造影响的稳健分析。

我们的分析方法强调定性输入的主题编码、材料性能特征的比较评估以及基于情境的关税和物流中断评估。我们承认专有製造数据或机密商业条款会限制全面了解情况。在这些情况下，我们透过多个独立资讯来源证实了我们的研究结果，以确保可靠性。我们的调查方法优先考虑在临床、监管和供应链方面保持平衡的观点，为商业和临床相关人员提供决策相关的见解。

将材料转型、医疗保健服务转变和贸易动态等核心策略要务整合到市场和产品决策的连贯蓝图中

总而言之，静脉输液袋产业正处于策略曲折点，材料科学、供应链韧性以及不断发展的医疗保健环境正在汇聚，重塑产品优先级和商业策略。相关人员必须认识到，向非PVC材料的转变、多腔和特殊输液形式日益增长的重要性以及医疗服务向门诊和家庭环境的分散化并非孤立的趋势，而是相互关联的因素，需要研发、製造和上市等职能部门的综合应对。

此外，关税和贸易环境正在加速对采购和库存策略的反思，那些将本地製造能力与有效的品质系统和强有力的监管途径相结合的公司将获得丰厚的回报。那些积极主动地将产品系列与临床工作流程相结合、投资于可追溯性和永续性，并儘早与采购负责人和监管机构接洽的公司，将最有可能将这些结构性变化转化为竞争优势。这些摘要见解为准备引领输液治疗解决方案下一阶段发展的领导者提供了策略蓝图。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 引入环保、可生物降解的静脉输液包装，以减少对环境的影响
  • 越来越多地采用整合物联网静脉输液袋的智慧输液帮浦进行远端患者监护
  • 在紧急医疗环境中，对具有延长保质期的预充式预填充袋的需求正在增加
  • 越来越多地采用床边条码扫描系统来即时检验静脉输液袋药物的准确性
  • 可依患者个体代谢需求客製化的肠外营养静脉输液袋需求激增

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章 静脉输液袋市场应用分析

  • 门诊治疗
  • 居家照护
  • 医院
    • 普通病房
    • ICU
    • 手术室

9. 静脉输液袋市场（依材质）

  • 非PVC
    • 乙烯醋酸乙烯酯
    • 聚烯
  • PVC

第十章 静脉输液袋市场（依包装类型）

  • 多室
    • 双腔
    • 三腔
  • 单室

第 11 章 静脉输液袋市场（依流量）

  • 宏滴
  • 微滴

第12章 静脉输液袋市场（依最终用户）

  • 门诊治疗中心
  • 诊所
  • 居家照护中心
  • 医院

第十三章 静脉输液袋市场（依产品类型）

  • 特殊药品管理
  • 标准IV溶液
  • 全静脉营养

第十四章 输液袋市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 15 章 静脉输液袋市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 IV 袋市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • Terumo Corporation
    • ICU Medical, Inc.
    • Pfizer Inc.
    • Nipro Corporation
    • Grifols, SA
    • Vygon SA
    • Otsuka Pharmaceutical Co., Ltd.
Product Code: MRR-43470FC6083B

The IV Bags Market is projected to grow by USD 47.27 billion at a CAGR of 7.27% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 26.95 billion
Estimated Year [2025] USD 28.91 billion
Forecast Year [2032] USD 47.27 billion
CAGR (%) 7.27%

A concise orientation to the multifaceted intravenous infusion environment highlighting clinical use cases, material evolutions, and the structured segments that define supplier and provider choices

Intravenous infusion systems remain a foundational component of acute and chronic care delivery, supporting fluid therapy, drug administration, nutrition, and emergency resuscitation in diverse clinical environments. Recent years have seen converging pressures that elevate the strategic importance of IV bag design and supply resilience: shifts in material science away from legacy plasticizers, heightened emphasis on patient safety and drug compatibility, and expanding delivery beyond institutional walls into homecare and ambulatory settings. Together, these forces require manufacturers and providers to reassess portfolio composition, procurement practices, and clinical workflows.

As stakeholders evaluate product choices, they must consider multiple dimensions of the market structure. Based on Application, market study accounts for Ambulatory Care, Homecare, and Hospital settings, with Hospital environments further delineated across General Ward, ICU, and Operating Theatre. Based on Material, focus spans Non-PVC and PVC formats, where Non-PVC options are further categorized into Ethylene Vinyl Acetate and Polyolefin. Based on Packaging Type, devices are examined across Multi-Chamber and Single Chamber configurations, with Multi-Chamber split into Dual Chamber and Triple Chamber options. Based on Flow Rate, clinical use differentiates Macrodrip and Microdrip systems. Based on End User, the landscape includes Ambulatory Care Centers, Clinics, Homecare Centers, and Hospitals. Based on Product Type, the market is analyzed across Specialty Drug Delivery, Standard IV Solutions, and Total Parenteral Nutrition. This multidimensional framing establishes a foundation for the deeper analytical themes explored in subsequent sections.

Identification of converging material, regulatory, and care-delivery transformations reshaping intravenous solution design, manufacturing prioritization, and clinical deployment strategies

The IV bags landscape is experiencing transformative shifts driven by material innovation, regulatory evolution, and shifts in care delivery models that collectively reconfigure product specification and procurement logic. Advances in polymer science are accelerating the adoption of alternatives to traditional PVC formulations, driven by concerns about plasticizer migration, drug compatibility, and environmental sustainability. Consequently, manufacturers are investing in Ethylene Vinyl Acetate and Polyolefin processing capabilities to meet clinician demands for safer, more chemically inert containers.

Concurrently, care delivery is decentralizing: ambulatory and homecare settings are playing an expanding role in therapies historically confined to hospitals, which places a premium on packaging formats that simplify administration and reduce risk in non-clinical environments. Multi-chamber systems that enable co-administration and extended stability are becoming more relevant for specialty drug delivery and total parenteral nutrition, while flow-rate tailored solutions such as macrodrip and microdrip devices are seeing differentiated clinical adoption. Moreover, digital traceability and single-use stewardship programs are altering lifecycle economics. Taken together, these trends create an imperative for suppliers to align R&D, manufacturing capacity, and regulatory strategies with shifting clinical and commercial parameters.

Analysis of the cumulative operational and commercial consequences stemming from tariff measures in 2025 and how they are influencing supplier strategy, inventory design, and procurement choices

The imposition of tariffs and related trade measures in 2025 has introduced a cumulative set of effects on procurement costs, supplier selection, and inventory strategies across the intravenous supply chain. Tariff-induced cost pressure has prompted downstream buyers to reassess sourcing geographies, with an emphasis on supplier diversification and nearshoring to buffer exposure to trade policy volatility. Procurement teams are increasingly balancing landed cost with supplier reliability, regulatory approvals, and quality certification when reconfiguring supplier tiers.

In practical terms, manufacturers and contract packagers have adjusted pricing models and renegotiated contracts with raw material suppliers to preserve margin while maintaining sterility and compliance standards. The heavier administrative burden for cross-border shipments has elevated the value of vertically integrated suppliers and regional manufacturing footprints capable of servicing local demand with reduced customs complexity. Inventory policies have shifted toward a hybrid approach that blends strategic safety stocks with just-in-time replenishment for high-turn items, supported by enhanced visibility tools. Overall, the tariff environment has accelerated structural adjustments that favor resilience, traceability, and flexible production capacity.

Detailed segmentation analysis uncovering how application, material choice, packaging architecture, flow characteristics, end-user contexts, and product types drive differentiated clinical and commercial requirements

Segmentation insights reveal nuanced trajectories across clinical settings, materials, packaging formats, flow configurations, end-user types, and product categories, each with distinct strategic implications. Application-wise, demand patterns differ between Ambulatory Care and Homecare versus Hospital environments, and hospitals themselves present differentiated needs across General Ward, ICU, and Operating Theatre use cases; this variation influences container robustness, compatibility specifications, and labeling clarity. Material selection is a critical differentiator: the move from PVC toward Non-PVC options such as Ethylene Vinyl Acetate and Polyolefin is motivated by drug interaction concerns and environmental considerations, and it necessitates corresponding changes in manufacturing processes and validation protocols.

Packaging type has emerged as a key point of product differentiation, with Single Chamber solutions remaining core for standard IV fluids while Multi-Chamber formats, including Dual Chamber and Triple Chamber designs, are gaining prominence in specialty drug delivery and therapies requiring admixture at the point of care. Flow rate segmentation between Macrodrip and Microdrip reflects clinical application specificity, with macrodrip favored for rapid fluid resuscitation and microdrip optimized for precise pediatric or ambulatory administration. End users span Ambulatory Care Centers, Clinics, Homecare Centers, and Hospitals, and each requires tailored training, labeling, and distribution approaches. Product-type distinctions among Specialty Drug Delivery, Standard IV Solutions, and Total Parenteral Nutrition further influence shelf-life requirements, compatibility testing, and cold-chain or controlled-environment packaging needs. These segmentation insights should guide product portfolio rationalization, investment in targeted manufacturing capabilities, and clinical market engagement.

Comparative regional perspectives explaining how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence manufacturing choices, regulatory navigation, and clinical adoption patterns

Regional dynamics are shaping both supply-side capacity and demand patterns, with each macro-region presenting distinct regulatory frameworks, manufacturing ecosystems, and clinical adoption curves. In the Americas, established clinical infrastructures and robust purchasing channels facilitate rapid adoption of new materials and higher-margin specialty products, while proximity between manufacturers and large healthcare systems supports close collaboration on compatibility testing and product trials. Across Europe, Middle East & Africa, regulatory heterogeneity and reimbursement variability create both challenges and opportunities for suppliers able to navigate national health systems and local certification pathways, and regional hubs continue to be important for distribution and localized manufacturing.

In the Asia-Pacific region, production scale and cost competitiveness remain central, supported by a growing number of polymer processors and contract manufacturers capable of supplying both domestic and export markets. The region also shows accelerating clinical adoption in ambulatory and homecare settings, which increases demand for packaging that is user-friendly and compatible with decentralized administration. Cross-region trade dynamics, including tariff considerations and logistics constraints, have encouraged a more localized approach to capacity planning, with many companies adopting regional manufacturing footprints to reduce lead times and regulatory friction. These geographic distinctions should inform market entry strategies, regulatory investment, and supply-chain design.

Insights into corporate strategies showing how manufacturers and suppliers are adopting material innovation, quality systems, and partnership models to capture clinical and commercial advantage

Company-level behavior reveals a set of common strategic responses: investments in material innovation, scaling of sterile manufacturing capacity, and pursuit of strategic partnerships or contract manufacturing agreements to accelerate capability deployment. Leading firms are differentiating through validated Non-PVC product lines that address drug compatibility and safety concerns, while others are optimizing PVC formulations where lifecycle cost and performance remain favorable. In parallel, a subset of companies is developing multi-chamber solutions and specialty delivery systems to capture higher-value clinical segments and to align with clinician needs for simplified admixture and reduced preparation time.

Operationally, firms are prioritizing regulatory harmonization, quality management systems, and digital traceability across manufacturing and distribution channels to meet buyer expectations for transparency and reliability. Several companies are also exploring sustainability initiatives, such as recyclable materials, reduced energy consumption in sterilization, and packaging minimization, as differentiators in procurement decisions. These strategic moves illustrate an industry balancing incremental product evolution with targeted innovation to address the combined pressures of clinical complexity, regulatory scrutiny, and supply-chain resiliency.

A concise set of prioritized, actionable recommendations for manufacturers, suppliers, and procurement leaders to enhance resilience, innovation, and market responsiveness in intravenous product portfolios

Industry leaders should adopt a set of prioritized, actionable steps that align operational capability with evolving clinical requirements and policy landscapes. First, diversify supplier bases and create regional manufacturing buffers to mitigate cross-border policy risk while preserving responsiveness to local demand; this will reduce disruption from tariff shifts and logistics volatility. Second, accelerate investment in Non-PVC materials such as Ethylene Vinyl Acetate and Polyolefin while maintaining validated PVC options where clinically appropriate, ensuring that product portfolios meet a spectrum of compatibility and sustainability criteria.

Third, prioritize multi-chamber and specialty delivery platforms for segments where admixture convenience and drug stability command clinical preference, and tailor packaging and labeling for ambulatory and homecare environments. Fourth, invest in digital traceability and inventory optimization tools to improve supply visibility and reduce waste, enabling hybrid inventory strategies that balance safety stocks with efficient turnover. Fifth, engage proactively with regulators and large purchasers to streamline approvals and align product specifications with procurement requirements. Finally, pursue targeted partnerships with clinical leaders to validate product performance in ICU, Operating Theatre, and home settings, thereby shortening adoption curves and strengthening value propositions.

A transparent explanation of research protocols combining primary clinician and supplier interviews with technical review, supply-chain mapping, and triangulated secondary analysis to support robust conclusions

This research synthesized evidence from structured primary interviews, technical white papers, regulatory filings, and public company disclosures, triangulated with supply-chain mapping and material-focused laboratory assessments. Primary research included conversations with clinicians across hospital wards, ICU teams, and ambulatory care practitioners, as well as procurement specialists, contract manufacturers, and polymer suppliers. Secondary sources provided contextual validation on regulatory trends, sterilization protocols, and device compatibility literature, supporting a robust analysis of product and manufacturing implications.

Analytical methods emphasized thematic coding of qualitative inputs, comparative assessment of material performance characteristics, and scenario-based evaluation of tariff and logistics disruptions. Limitations are acknowledged where proprietary manufacturing data or confidential commercial terms constrains full visibility; in these instances, findings were corroborated through multiple independent sources to ensure reliability. The methodology prioritizes a balanced view across clinical, regulatory, and supply-chain dimensions to furnish decision-relevant insights for commercial and clinical stakeholders.

Synthesis of core strategic imperatives that tie material transitions, care delivery shifts, and trade dynamics into a cohesive roadmap for market and product decisions

In conclusion, the IV bags sector is at a strategic inflection point where material science, supply-chain resilience, and evolving care settings converge to reshape product priorities and commercial strategies. Stakeholders must recognize that the shift toward Non-PVC materials, the growing relevance of multi-chamber and specialty delivery formats, and the decentralization of care into ambulatory and home settings are not isolated trends but interconnected drivers that together demand integrated responses across R&D, manufacturing, and market access functions.

Moreover, the tariff and trade environment has accelerated a rethinking of sourcing and inventory strategies, rewarding firms that combine regional capacity with validated quality systems and strong regulatory pathways. Companies that proactively align product portfolios with clinical workflows, invest in traceability and sustainability, and engage early with purchasers and regulators will be best positioned to convert these structural shifts into competitive advantage. The summary insights presented here offer a strategic roadmap for leaders preparing to navigate the next phase of evolution in intravenous therapy solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Implementation of eco-friendly biodegradable materials in intravenous fluid packaging to reduce environmental impact
  • 5.2. Rising adoption of smart infusion pumps integrated with IoT-enabled intravenous bags for remote patient monitoring
  • 5.3. Increasing demand for prefilled intravenous solution bags with extended shelf life in emergency care settings
  • 5.4. Growing adoption of bedside barcode scanning systems for real-time verification of IV bag medication accuracy
  • 5.5. Surge in demand for customizable parenteral nutrition IV bags tailored to individual patient metabolic requirements

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. IV Bags Market, by Application

  • 8.1. Ambulatory Care
  • 8.2. Homecare
  • 8.3. Hospital
    • 8.3.1. General Ward
    • 8.3.2. ICU
    • 8.3.3. Operating Theatre

9. IV Bags Market, by Material

  • 9.1. Non-PVC
    • 9.1.1. Ethylene Vinyl Acetate
    • 9.1.2. Polyolefin
  • 9.2. PVC

10. IV Bags Market, by Packaging Type

  • 10.1. Multi-Chamber
    • 10.1.1. Dual Chamber
    • 10.1.2. Triple Chamber
  • 10.2. Single Chamber

11. IV Bags Market, by Flow Rate

  • 11.1. Macrodrip
  • 11.2. Microdrip

12. IV Bags Market, by End User

  • 12.1. Ambulatory Care Centers
  • 12.2. Clinics
  • 12.3. Homecare Centers
  • 12.4. Hospitals

13. IV Bags Market, by Product Type

  • 13.1. Specialty Drug Delivery
  • 13.2. Standard IV Solutions
  • 13.3. Total Parenteral Nutrition

14. IV Bags Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. IV Bags Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. IV Bags Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Baxter International Inc.
    • 17.3.2. B. Braun Melsungen AG
    • 17.3.3. Fresenius Kabi AG
    • 17.3.4. Terumo Corporation
    • 17.3.5. ICU Medical, Inc.
    • 17.3.6. Pfizer Inc.
    • 17.3.7. Nipro Corporation
    • 17.3.8. Grifols, S.A.
    • 17.3.9. Vygon SA
    • 17.3.10. Otsuka Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IV BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IV BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IV BAGS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IV BAGS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IV BAGS MARKET SIZE, BY FLOW RATE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IV BAGS MARKET SIZE, BY FLOW RATE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IV BAGS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL IV BAGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL IV BAGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS IV BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL IV BAGS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. IV BAGS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. IV BAGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IV BAGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IV BAGS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IV BAGS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL IV BAGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL IV BAGS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS IV BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS IV BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. GLOBAL IV BAGS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 324. GLOBAL IV BAGS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 325. ASEAN IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. ASEAN IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. ASEAN IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. ASEAN IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. ASEAN IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 330. ASEAN IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 331. ASEAN IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 332. ASEAN IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 333. ASEAN IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 334. ASEAN IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 335. ASEAN IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. ASEAN IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. ASEAN IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 338. ASEAN IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 339. ASEAN IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 340. ASEAN IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 341. ASEAN IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. ASEAN IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 343. ASEAN IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 344. ASEAN IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 345. GCC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 346. GCC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 347. GCC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 348. GCC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 349. GCC IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 350. GCC IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 351. GCC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 352. GCC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 353. GCC IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 354. GCC IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 355. GCC IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 356. GCC IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 357. GCC IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 358. GCC IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 359. GCC IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 360. GCC IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 361. GCC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 362. GCC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 363. GCC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 364. GCC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 365. EUROPEAN UNION IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 366. EUROPEAN UNION IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 367. EUROPEAN UNION IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 368. EUROPEAN UNION IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 369. EUROPEAN UNION IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 370. EUROPEAN UNION IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 371. EUROPEAN UNION IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 372. EUROPEAN UNION IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 373. EUROPEAN UNION IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 374. EUROPEAN UNION IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 375. EUROPEAN UNION IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 376. EUROPEAN UNION IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 377. EUROPEAN UNION IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 378. EUROPEAN UNION IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 379. EUROPEAN UNION IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 380. EUROPEAN UNION IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 381. EUROPEAN UNION IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 382. EUROPEAN UNION IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 383. EUROPEAN UNION IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 384. EUROPEAN UNION IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 385. BRICS IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION